Eva Doleželová

Eva Doleželová is a Medical Science Partner in Neurology at Roche, where they work with a deep understanding of health technology assessment (HTA) and reimbursement regulations for innovative medicinal products. They previously served as the Head of the Medicines Evaluation Unit at the State Institute for Drug Control and held roles as an Assistant Professor and Research Scientist at Charles University. Doleželová has published scientific data in international journals and presented at conferences both locally and abroad, while also lecturing on pharmacology, pathophysiology, cell biology, and genetics in Czech and English. They completed a PhD in Pharmacology and Toxicology at Charles University, where they have been engaged in academic research and education since 2005.